Articles On Neurotech International (ASX:NTI)

Title Source Codes Date
New autism study for Neurotech's medicinal cannabis

Neurotech International (ASX:NTI) has announced the commencement of a phase 1/2 open-label clinical study in 20 children aged between 5-17 years with Autism Spectrum Disorder.

BiotechDispatch NTI 4 days ago
Here’s why ASX healthcare shares Neurotech and AFT Pharma are trending today

Summary Neurotech International has commenced Phase I/II open-label clinical trial in children having Autism Spectrum Disorder. Multinational pharmaceutical company AFT Pharmaceuticals disclosed the extension of licensing of Maxigesic®...

Kalkine Media NTI 5 days ago
Neurotech embarks on ground-breaking ASD trials

Neurotech International Limited (ASX:NTI) has commenced a Phase I/II open label clinical study in 20 children aged between 5-17 years with Autism Spectrum Disorder (ASD). This much-anticipated study is being conducted under the guidance and...

FinFeed NTI 5 days ago
Neurotech makes significant progress with world’s first cannabidiol drug for children with autism

The company’s preparations over the last quarter means that it is now ready to conduct Phase I and II studies on its medicinal cannabis for autistic children. Neurotech International (ASX:NTI) has released an update on its quarterly activit...

Stockhead NTI 6 days ago
Capital Raisings Recap: Nearly $10 billion has already been raised in 2021

The capital raisings boom on the ASX is continuing in 2021 with nearly $10 billion raised in the first four months of the year. Across 325 deals, ASX companies have raised $9.878 billion in capital amidst IPOs, placements and rights issues....

Stockhead NTI 1 week ago
Hot Pot Stocks: Here are 8 ASX plays that have tripled in the last 12 months

ASX pot stocks have run hot in recent months but eight in particular have been particularly rewarding for shareholders. Many pot stocks ran cold prior to COVID-19 as regulatory progress stalled and global markets didn’t take off. Australia...

Stockhead NTI 1 week ago
Weed Week: Oz cannabis revenue expected to double in 2021 as patients soar

Australia’s medical marijuana industry is showing strong growth, according to an industry-leading biannual report. The Freshleaf Analytics report, released this morning, says that patient numbers have grown 15-fold over the past two and a h...

Stockhead NTI 1 month ago
NTI secures strategic Cultivation partnership to grow and maintain its medical cannabis

Neurotech International Limited (ASX:NTI) has announced a strategic cultivation partnership with CannaPacific Limited to grow and maintain genetic stock and assist in the development of elite varietal strains through their exclusive licenci...

FinFeed NTI 2 months ago
Neurotech expands exclusive license to include all neurological disorders

Neurotech International Limited (ASX:NTI) has expanded its exclusive license with Dolce Cann Global Pty Ltd to now include all neurological disorders, disease or affliction affecting the human brain function, specifically - Autism, Epilepsy...

FinFeed NTI 2 months ago
Neurotech to commence clinical study program this quarter

Neurotech International Limited (ASX:NTI) has provided an update on its clinical study program. As we reported in late December, Neurotech successfully completed a series of in vitro studies that demonstrated that the NTI/Dolce strains, wit...

FinFeed NTI 2 months ago
Neurotech’s key near-term objectives

Neurotech International Limited (ASX:NTI) has provided a comprehensive overview and update regarding the company’s cannabis strains, development strategy and some of the key near-term objectives expected to be delivered. Neurotech is a medi...

FinFeed NTI 3 months ago
NTI Complete In Vitro Studies on Cannabis Strains, Clinical Trials Await

Neurotech International Ltd (ASX:NTI) has today confirmed the successful completion of in-vitro studies using human brain cells to assess and validate the anti-inflammatory and neuro-modulatory properties of its proprietary DOLCE/NTI cannab...

FinFeed NTI 4 months ago
Crucial Lab Results Are Imminent, Will Neurotech Rerate?

–The below is a company sponsored announcement– ASX cannabis stocks are gaining momentum, stimulated by significant developments in the global regulatory environments in recent months. On the cusp of a potential rerate is $29M capped Neur...

FNArena NTI 4 months ago
Neurotech poised to commence clinical trials in March quarter

The last month has been an extremely rewarding period for Neurotech International Limited (ASX:NTI) with the company commencing stage 1 clinical product formulation and development studies in mid-November with a view to entering into clinic...

FinFeed NTI 4 months ago
Lab tests confirm neuro-protective potency of Neurotech’s unique strains of cannabis

Special Report: Neurotech International (ASX:NTI) says laboratory tests have confirmed the neuro-protective, anti-inflammatory and neuro-modulatory activities of seven special cannabis ... Read More The post Lab tests confirm neuro-protecti...

Stockhead NTI 5 months ago
Hidden Gems Webinar Recap – NTI, RLG, 3DP, EMV

ShareCafeHidden Gems Webinar Recap – NTI, RLG, 3DP, EMV Catch up on the full webinar with presentations from EMVision (ASX:EMV), Pointerra (ASX:3DP), Roolife Group (ASX:RLG) and Neurotech International (ASX: NTI). Hidden Gems Webinar Recap...

ShareCafe NTI 5 months ago
Neurotech International (ASX: NTI) – Hidden Gems Webinar Presentation

ShareCafeNeurotech International (ASX: NTI) – Hidden Gems Webinar Presentation Presenter – Brian Leedman – Chairman – Neurotech international limited, or Nurotech is a medical device and solutions company incorporated in Australia, operati...

ShareCafe NTI 5 months ago
Neurotech gets new chairman, makes pivot to cannabis space official

Special Report: Neurotech International (ASX:NTI) has a new chairman and a new focus – cannabis treatments for cognitive disorders, rather ... Read More The post Neurotech gets new chairman, makes pivot to cannabis space official appeared f...

Stockhead NTI 6 months ago
Neurotech’s unique cannabis strains may be better than CBD

Special Report: Austism treatment specialist Neurotech International says unique strains of cannabis it has obtained may hold the key to ... Read More The post Neurotech’s unique cannabis strains may be better than CBD appeared first on Sto...

Stockhead NTI 7 months ago
Closing Bell: Today’s biggest small cap movers on the ASX

A quick wrap of the ASX’s key winners and losers on Friday, August 21. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Today 830 stocks rose, 552 declined and 7...

Stockhead NTI 8 months ago
Closing Bell: Today’s biggest small cap movers on the ASX

A quick wrap of the ASX’s key winners and losers on Tuesday, August 18. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Today 888 stocks rose, 534 declined and...

Stockhead NTI 8 months ago
Closing Bell: Today’s biggest small cap movers on the ASX

A quick wrap of the ASX’s key winners and losers on Wednesday, July 22. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Today 630 stocks rose, 765 declined and...

Stockhead NTI 9 months ago
Closing Bell: Today’s biggest small cap movers on the ASX

A quick wrap of the ASX’s key winners and losers on Tuesday, July 21. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made potentially market-moving announcements during the day. Today 1032 ASX stocks rose, 38...

Stockhead NTI 9 months ago
Closing Bell: Today’s biggest small cap movers on the ASX

A quick wrap of the key winners and losers on Monday, July 6. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Today 712 stocks rose, 576 declined and 819 were u...

Stockhead NTI 10 months ago
Neurotech to treat autism, epilepsy and ADHD using Dolce Cann’s proprietary cannabis strains

Neurotech International (ASX: NTI) has collared an exclusive global licence to use Dolce Cann Global’s cannabis strains to treat autism, epilepsy and ADHD. Dolce is an Australian based medicinal cannabis company that has created proprietary...

SmallCaps NTI 10 months ago
Closing Bell: Today’s biggest small cap movers on the ASX

A quick wrap of the key winners and losers on Wednesday, June 24. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Today 741 stocks rose, 697 declined and 764 we...

Stockhead NTI 10 months ago
Closing Bell: Today’s biggest small cap movers on the ASX

A quick wrap of the key winners and losers on Friday, June 19. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Today 806 stocks rose, 483 declined and 825 were...

Stockhead NTI 10 months ago
Check up: Sometimes no news is good news

Here’s our fortnightly wrap of all the news driving ASX health stocks. Of the ASX’s 134-odd small cap health stocks and of those which were trading on Wednesday, 71 were in positive territory over the last fortnight, 11 were flat and 52 saw...

Stockhead NTI 10 months ago
Closing Bell: Today’s biggest small cap movers on the ASX

A quick wrap of the key winners and losers on Tuesday, June 9. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made potentially market-moving announcements during the day.   WINNERS: CODE COMPANY PRI...

Stockhead NTI 11 months ago
10 at 10: These ASX stocks are brewing a storm this morning

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead NTI 11 months ago
Bondi backpackers rejoice! Recce may have a gonorrhoea cure

Backpackers in Bondi were pilloried for spreading COVID-19, but everyone knows gonorrhoea is a greater risk in the suburb’s sandy stews. Antibiotic maker Recce Pharmaceuticals (ASX: RCE) says its lead candidate is proving to be effective ag...

Stockhead NTI 1 year ago
WA biotechs are booming; now government wants to make the state a life sciences hub

With the health and life science sector being the ASX’s top performer last year, Western Australia is keen to join the party. The state government has formed an Industry Reference Group to come up with a five-year growth plan for the indust...

Stockhead NTI 1 year ago
ASX Today: Renewed virus fears send ASX tumbling

The ASX had its worst day of the year so far as it woke up from Australia Day weekend to find global markets retreating on the back of renewed coronavirus fears. The benchmark ASX 200 index shaved off more than a week’s worth of gains a...

themarketherald.com.au NTI 1 year ago
Neurotech International (ASX:NTI) can no longer sell its flagship product in Australia

Autism treatment company Neurotech International (NTI) has had its flagship device cancelled from the Australian Registry of Therapeutic Goods The device, called Mente Autism, was cancelled after failing a review by the Therapeutic Goods...

themarketherald.com.au NTI 1 year ago
Health: Antisense’s anti-muscular dystrophy drug just took a big step

Antisense Therapeutics (ASX:ANP) jumped over 20 per cent this morning on news its ATL1102 drug, fighting Duchenne Muscular Dystrophy (DMD), delivered strong preliminary results in its clinical trial. The stock is now up 270 per cent over th...

Stockhead NTI 1 year ago
10 at 10: These ASX stocks are on the move this morning

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead NTI 1 year ago
10 at 10: These ASX stocks are on the move this morning

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead NTI 1 year ago
Triplets: The 10 ASX small caps that more than tripled in a day in 2019

In 2019, 10 stocks have gained more than 200 per cent in a single day. Stockhead recaps these stocks, why they gained and where they are now.   10. AssetOwl (ASX: AO1) +225% (16 April) A fellow micro-cap gave AssetOwl a massive leg up back...

Stockhead NTI 1 year ago
In 2019, 23 stocks have jumped over 100pc in one day. Why and where are they now?

At Stockhead we are as amazed as our readers when stocks rise by over 100 per cent in a day. But its a more common occurrence than we thought. There have been 23 stocks that have achieved that feat. The three most common reasons are success...

Stockhead NTI 1 year ago
Autism Trial Results a Major Boost for NTI’s Proprietary Tech & Children with Autism

Leading medical device company Neurotech International (ASX:NTI) this week reported highly promising results from US clinical trials of its Mente autism device.

NextBiotech NTI 2 years ago